Producer of monoclonal and polyclonal antibodies for experimental use. Products are sold to academic, government and corporate researchers. The bulk of revenue is derived from activity in the biotechnology industry. This company was capitalized by private investment. Products include human diagnostic polyclonal antibodies, human diagnostic monoclonal antibodies.